What is Vidac Pharma?
Vidac Pharma operates as a specialized biopharmaceutical entity dedicated to the development of first-in-class oncologic and onco-dermatologic therapies. The company distinguishes itself through a breakthrough technological approach that targets the metabolic dysregulation inherent in cancer cells. By correcting these fundamental cellular characteristics, Vidac Pharma aims to integrate its solutions into standard oncology combination therapies, effectively positioning itself as a critical player in the evolving landscape of precision medicine and cancer care. Its research pipeline is designed to address high-unmet needs in both systemic oncology and dermatological manifestations of malignancy.
How much funding has Vidac Pharma raised?
Vidac Pharma has raised a total of $9.6M across 2 funding rounds:
Series A
$9M
Other Financing Round
$645K
Series A (2016): $9M with participation from Israel Biotech Fund
Other Financing Round (2024): $645K, investors not publicly disclosed
Key Investors in Vidac Pharma
Israel Biotech Fund
A specialized investment firm based in Rehovot, Israel, focusing on high-potential opportunities within the biotechnology and life sciences sectors.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Vidac Pharma?
With the recent influx of capital, Vidac Pharma is well-positioned to accelerate its clinical development programs and expand its therapeutic reach. The strategic roadmap likely involves advancing its lead candidates through rigorous clinical trials while strengthening its intellectual property portfolio. As the company transitions into more advanced stages of development, the focus will shift toward establishing key partnerships with larger pharmaceutical entities to facilitate commercialization and global distribution. The current funding environment suggests a robust outlook for the firm as it seeks to validate its novel mechanism of action within the broader oncology market, potentially setting a new standard for combination therapy protocols.
See full Vidac Pharma company page
